Rates of Herpes simplex virus, cytomegalovirus, human herpesvirus 6, and Epstein-Barr virus in schizophrenia: Systematic review and meta-analysis
This systematic review and meta-analysis of 36 studies found no significant association between schizophrenia and infections with HSV, HHV-6, or EBV, but identified a significant protective effect of cytomegalovirus (CMV) infection against the development of schizophrenia.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human brain is a complex organ that begins its intricate development long before birth, guided by a delicate interplay of genetic instructions and environmental influences. When this development goes awry, it can lead to severe psychiatric conditions like schizophrenia, a disorder that distorts a person's perception of reality, thoughts, and emotions. For decades, scientists have searched for the specific triggers that might disrupt this early formation. One persistent line of inquiry has focused on the herpesvirus family, a group of common viruses that includes the agents behind cold sores, chickenpox, and mononucleosis. These viruses are known for their ability to hide quietly in the body's nerve cells for years, occasionally waking up to cause trouble. Because they have a strong affinity for the nervous system, researchers have long wondered if a past infection with one of these viruses could act as a hidden spark, igniting the neurodevelopmental changes that eventually lead to schizophrenia.
To settle this question, a team of researchers from Jiroft University of Medical Sciences in Iran set out to gather every available piece of evidence on the subject. They conducted a massive review, combing through scientific databases to find studies that had compared people with schizophrenia to healthy individuals. Their goal was to see if the rates of infection with four specific herpesviruses—Herpes simplex virus type 1, Herpes simplex virus type 2, cytomegalovirus, and Epstein-Barr virus—were different between the two groups. By combining data from thirty-six separate studies involving thousands of participants, they created a clearer picture than any single study could provide on its own. The team looked for antibodies, which are proteins the immune system creates to fight off viruses, or the genetic material of the viruses themselves in samples taken from blood, spinal fluid, or brain tissue.
The results of this comprehensive analysis offered a surprising twist to the long-held theory that these viruses are a primary cause of the disorder. When the researchers looked at the group as a whole, they found no evidence that infection with the herpesvirus family, in general, increased the risk of developing schizophrenia. In fact, the prevalence of these infections was nearly identical in patients with the disorder and in healthy people, hovering around 36 percent for both groups. When they broke the data down by specific virus, the findings remained largely consistent with this lack of connection. Infections with Herpes simplex virus type 1, which causes most cold sores, showed no link to the illness. The same was true for Herpes simplex virus type 2, Epstein-Barr virus, and human herpesvirus 6. The data suggested that carrying these common viruses does not, by itself, make a person more likely to develop schizophrenia.
However, one virus stood out as an exception, presenting a result that challenges the prevailing narrative. The analysis revealed that infection with cytomegalovirus was actually associated with a lower risk of developing schizophrenia. The data indicated that individuals with this specific infection were less likely to have the disorder compared to those without it. This finding suggests a protective effect, a possibility that runs counter to the idea that all herpesviruses are harmful to brain development. The researchers noted that while cytomegalovirus is known to cause serious issues if a fetus is infected during pregnancy, its presence in the general population did not correlate with higher rates of the psychiatric condition in this study. Instead, the numbers pointed toward a potential shield, though the authors cautioned that this result requires further investigation to understand the underlying mechanism.
Despite these clear patterns, the researchers were careful to highlight the limitations of their work. The studies they analyzed varied widely in how they were conducted, where they took place, and the methods used to detect the viruses, which introduced a degree of uncertainty into the final numbers. The team also pointed out that most of the data came from the United States, meaning the results might not fully reflect the global picture. Furthermore, the possibility of publication bias—where studies with positive or negative results are more likely to be published than those with no findings—could have influenced the outcome. Consequently, while the data strongly suggests that most herpesviruses are not the cause of schizophrenia and that cytomegalovirus might even be protective, the authors concluded that the story is not yet fully written. They emphasized that larger, more diverse studies are needed to confirm these findings and to explore how these viruses might interact with other factors in the complex puzzle of mental health.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.